ethisterone and Substance-Withdrawal-Syndrome

ethisterone has been researched along with Substance-Withdrawal-Syndrome* in 1 studies

Trials

1 trial(s) available for ethisterone and Substance-Withdrawal-Syndrome

ArticleYear
Suppression of estrogen-withdrawal headache with extended transdermal contraception.
    Fertility and sterility, 2005, Volume: 83, Issue:6

    A randomized clinical trial was conducted with 239 women at nine clinical research sites to compare bleeding profile, headache frequency, and subject satisfaction with the transdermal contraceptive, ORTHO EVRA (norelgestromin/ethinyl estradiol transdermal system) used in an extended regimen (84 days) with a traditional, 28-day cyclic regimen. In a majority of women studied, compared with cyclic use, extended use of transdermal norelgestromin/ethinyl estradiol delayed menses and reduced the total incidence of mean headache days during the hormone-free interval.

    Topics: Administration, Cutaneous; Adolescent; Adult; Delayed-Action Preparations; Drug Combinations; Ethisterone; Female; Headache; Humans; Middle Aged; Norgestrel; Oximes; Substance Withdrawal Syndrome; Time Factors

2005